Dr. Tikhonova is a Scientist at the Princess Margaret Cancer Centre and an Assistant Professor in the Department of Medical Biophysics at the University of Toronto. Dr. Tikhonova is a recipient of an Investigator Award from the Ontario Institute for Cancer Research (OICR) to support her research program on dissecting and targeting the tumor microenvironment and contributes to OICR’s Acute Leukemia Translational Research Initiative. Among other honours, Dr. Tikhonova is also a recipient of the Gilead Research Scholar Award and the American Society of Hematology Scholar Award. She is a Founding member and a Co-chair of the Gender Equity Committee at the Princess Margaret Cancer Centre.
Dr. Anastasia Tikhonova completed her dissertation research in the laboratory of Dr. Alfred Singer at the National Cancer Institute, as part of the NIH-University of Pennsylvania Graduate Partnership in Immunology (2007-2011). There, she became interested in how microenvironmental factors dictate cell fate choices. Dr. Tikhonova continued her training in the laboratory of Dr. Iannis Aifantis (New York University Medical School), where she identified niche factors that govern hematopoietic stem cell differentiation and leukemia progression (2012-2019).